New hope for severe diabetes: trial tests drug to protect transplanted insulin cells
NCT ID NCT06305286
Summary
This study is testing a new drug, Tegoprubart, combined with standard medications to see if it can safely help transplanted islet cells survive and produce insulin in people with severe type 1 diabetes. The goal is to reduce or eliminate the need for insulin injections and prevent dangerous low blood sugar episodes. Researchers are enrolling 70 adults who have type 1 diabetes with frequent, unexplained severe low blood sugar events.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University of Chicago
RECRUITINGChicago, Illinois, 60637, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.